Solventum Corporation

    Jurisdiction
    United States
    ISIN
    US83444M1018 (SOLV)
    Sectors
    1. Healthcare
    2. Medical - Care Facilities

    Scores

    Fair value (Benjamin Graham formula)
    €132.36 113.5% undervalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. Read full profile

    Fundamentals

    Net revenue
    €7.15B
    Gross margin
    54.5%
    EBIT
    €662.74M
    EBIT margin
    9.3%
    Net income
    €324.12M
    Net margin
    4.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €6.83B -4.6% €941.27M +190.4%
    €6.99B +2.5% €1.04B +10.9%
    €7.24B +3.6% €1.18B +13.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    3M CO N/A -8.8M $73.45 -$646.36M

    Congress transactions

    Name Transaction date Value
    Julie Johnson February 12, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 14K $1.07M -2.8K Sell
    Ray Dalio 3.8K $287.51K -5.5K Sell

    Earnings Calls

    Add to watchlist

    Notifications